Get started
Author

Aws Khalid Abushanab

Observed names: Abushanab, Aws Khalid, Aws Abushanab
Observed institution: Hashemite University
ORCID: 0000-0003-0874-666X
Observed ORCID: 0000-0003-0874-666X
OpenAlex ID: A5068391438
The efficacy and safety of Capivasertib (AZD5363) in the treatment of patients with solid tumor: a systematic review and meta-analysis of randomized clinical trials
2023 · Aws Khalid Abushanab, Mahmoud Taysir Mousa, et al. · Expert Opinion on Drug Safety · 11
Efficacy and safety of entinostat plus exemestane in hormone receptor-positive breast cancer: a systematic review meta-analysis of randomized controlled trials
2025 · Nour Maher Mustafa, Mus’ab Theeb Mustafa, et al. · Breast Cancer Research and Treatment · 9
Efficacy and safety of tislelizumab for malignant solid tumor: a systematic review and meta-analysis of phase III randomized trials
2023 · Aws Khalid Abushanab, Mus’ab Theeb Mustafa, et al. · Expert Review of Clinical Pharmacology · 7
Safety and efficacy of Rucaparib in the treatment of ovarian cancer and patients with BRCA mutation: a systematic review and meta-analysis of phase III randomized clinical trials
2024 · Mus’ab Theeb Mustafa, Aws Khalid Abushanab, et al. · Expert Review of Anticancer Therapy · 4
Immune checkpoint inhibitors plus taxane-based chemotherapy for patients with advanced/metastatic NSCLC: a systematic review and meta-analysis across different PD-L1 expression levels
2025 · Aws Khalid Abushanab, Mus’ab Theeb Mustafa, et al. · Expert Review of Anticancer Therapy · 2
Safety profile of dual TIGIT and PD-L1 blockade with tiragolumab plus atezolizumab in solid tumors: a systematic review and meta-analysis of randomized controlled trials
2026 · Zaher Mutaz Ashour, Mus’ab Theeb Mustafa, et al. · Figshare
Safety profile of dual TIGIT and PD-L1 blockade with tiragolumab plus atezolizumab in solid tumors: a systematic review and meta-analysis of randomized controlled trials
2026 · Zaher Mutaz Ashour, Mus’ab Theeb Mustafa, et al. · Expert Opinion on Drug Safety
Efficacy and Safety of Tocilizumab Biosimilars Compared to Reference Tocilizumab in the Treatment of Rheumatoid Arthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials
2026 · Mus'ab Theeb Mustafa, Ahmad Yousef Alazzam, et al. · Current Rheumatology Reviews
Abstract 3787: The safety of PARP inhibitors combined with immune checkpoint inhibitors versus immune checkpoint inhibitor monotherapy: A systematic review, meta-analysis, and trial sequential analysis of randomized controlled trials
2026 · Mus'ab Theeb Mustafa, Aws Khalid Abushanab, et al. · Cancer Research
Safety and efficacy of spleen tyrosine kinase (Syk) inhibitors in the treatment of adults with persistent and chronic immune thrombocytopenia ( ITP ): A systematic review and meta‐analysis of randomised clinical trials
2026 · Mus'ab Theeb Mustafa, Aws Khalid Abushanab, et al. · British Journal of Haematology
PDF
Safety of alisertib in the treatment of solid and hematological cancers: A systematic review and meta-analysis of randomized controlled trials
2025 · Zaher Mutaz Ashour, Aws Khalid Abushanab, et al. · Journal of Oncology Pharmacy Practice
Iatrogenic effect of immune checkpoint inhibitors and targeted therapies on the lower gastrointestinal tract
2025 · Dua Abuquteish, Ahmad Yousef Alazzam, et al. · Frontline Gastroenterology
PDF
The predictive value of BRCA mutation on survival of cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis of phase III randomized clinical trials.
2025 · Mus'ab Theeb Mustafa, Aws Abushanab, et al. · Journal of Clinical Oncology
PDF
The efficacy and safety of Capivasertib (AZD5363) in the treatment of patients with solid tumor: a systematic review and meta-analysis of randomized clinical trials
2023 · Abushanab, Aws Khalid, Mousa, Mahmoud Taysir, et al. · Figshare
Works count: 16
Citation count: 33
H-index: 4
I10-index: 1
Year
Topic
Type